Condition
Menstrually Related Migraine
Total Trials
2
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Not Yet Recruiting1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07576309Not ApplicableCompleted
Repetitive GON Blockade for Menstrual Migraine
NCT06173661Phase 4Active Not Recruiting
Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
NCT07023926Not ApplicableNot Yet RecruitingPrimary
The Efficacy and Safety of Acupuncture for Prophylaxis of Menstrually Related Migraine
Showing all 3 trials